Mr. Gregory Warwick Taylor, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 34 Jerome Ave Ste 204, Bloomfield, CT 06002 Phone: 860-966-9680 Fax: 860-206-6075 |
Richard Judd Miller, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 3 Northwestern Dr, Bloomfield, CT 06002 Phone: 860-243-3477 Fax: 860-793-3500 |
Mrs. Jessica Listorti, PMHNP Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 693 Bloomfield Ave Ste 101, Bloomfield, CT 06002 Phone: 860-697-3372 |
Dr. Michael M Krinsky, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 580 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-243-9709 Fax: 860-243-2522 |
Ranjani Kurukulasuriya, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 693 Bloomfield Ave, Bloomfield, CT 06002 Phone: 860-243-6584 Fax: 860-243-6591 |
News Archive
WellPoint, Inc. today cancelled its Investor Day previously scheduled for February 23, 2010, and announced that management will review the Company's 2010 financial outlook during a conference call on March 17, 2010, at 8:30 a.m. Eastern Daylight Time (EDT). The Company continues to expect full year 2010 net income to be at least $6.00 per share, subject to its ability to secure and maintain sufficient premium rates.
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Fundamental research undertaken under the supervision of Professor Ute Hellmich of Johannes Gutenberg University Mainz has revealed a promising strategy to develop a suitable agent.
One in five young adults in India has high blood pressure, according to research presented at the 70th Annual Conference of the Cardiological Society of India. That equates to around 80 million people, which is more than the entire UK population.
Armetheon, Inc., a clinical stage biopharmaceutical company, announced today that it plans to develop its novel oral anti-coagulant (OAC), tecarfarin (ATI-5923), for a patient population which includes those who have prosthetic heart valves or chronic renal dysfunction.
A Heritage Foundation-affiliated conservative advocacy group, Heritage Action, will begin targeting lawmakers "at home in their districts" who fail to support the GOP-led efforts to repeal the overhaul with political ads and other tactics, according to The Hill, which quoted Michael Needham, the just-launched Action group's CEO "The effects of Obamacare are being felt more and more every day.
› Verified 7 days ago